CD14+ CD16- classical monocytes expressed significantly lower levels of CD40 on the cell surface compared to the intermediate and non-classical monocyte subtypes in both healthy controls and MS (Fig 4B). This evidence concerns the gene CD40 and myeloid sarcoma.